XML 36 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
Note 14 - Segment Information
12 Months Ended
Dec. 30, 2023
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]

14.    SEGMENT INFORMATION

 

The Company follows ASC280, “Segment Reporting,” which establishes standards for companies to report information about operating segments, geographic areas and major customers. The accounting policies of each reportable segment are the same as those described in the summary of significant accounting policies (see Note 1 to the Company’s Consolidated Financial Statements).

 

Segment operating income (loss) includes selling, general and administrative expenses directly attributable to that segment as well as charges for allocating corporate costs to each of the operating segments. The following tables reflect the results of the reportable segments consistent with the Company’s management system:

 

Fiscal Year Ended

December 30, 2023

Specialty

Health Care

  

Engineering

  

Life Sciences

and IT

  

Corporate

  

Total

 
                    

Revenue

$136,241  $84,675  $42,321  $-  $263,237 
                    

Cost of services

 96,309   64,071   26,161   -   186,541 
                    

Gross profit

 39,932   20,604   16,160   -   76,696 
                    

Selling, general and administrative

 26,010   16,964   9,211   -   52,185 
                    

Depreciation and amortization of

property and equipment

 383   504   145   -   1,032 
                    

Amortization of acquired intangible assets

 -   -   182   -   182 
                    

Gain on sale of assets

 -   (395)  -   -   (395)
                    

Operating income

$13,539  $3,531  $6,622  $-  $23,692 
                    

Total assets as of December 30, 2023

$43,769  $46,425  $18,586  $11,704  $120,484 

Property and equipment acquired

$141  $724  $123  $1,943  $2,931 

 

 

 

Fiscal Year Ended

December 31, 2022

Specialty

Health Care

  

Engineering

  

Life Sciences

and IT

  

Corporate

  

Total

 
                    

Revenue

$159,448  $85,937  $39,295  $-  $284,680 
                    

Cost of services

 111,543   64,218   25,992   -   201,753 
                    

Gross profit

 47,905   21,719   13,303   -   82,927 
                    

Selling, general and administrative

 27,661   17,272   8,462   -   53,395 
                    

Depreciation and amortization of

property and equipment

 426   455   114   -   995 
                    

Amortization of acquired intangible assets

 -   -   46   -   46 
                    

Remeasurement of acquisition-related

contingent consideration

 -   (88)  -   -   (88)
                    

Gain on sale of assets

 -   (219)  -   -   (219)
                    

Operating income

$19,818  $4,299  $4,681  $-  $28,798 
                    

Total assets as of December 31, 2022

$34,062  $33,447  $15,778  $4,677  $87,964 

Property and equipment acquired

$75  $657  $124  $296  $1,152 

 

 

 

Fiscal Year Ended

January 1, 2022

Specialty Health Care

  

Engineering

  

Life Sciences and IT

  

Corporate

  

Total

 
                    

Revenue

$98,495  $66,172  $39,208  $-  $203,875 
                    

Cost of services

 73,177   50,109   27,465   -   150,751 
                    

Gross profit

 25,318   16,063   11,743   -   53,124 
                    

Selling, general and administrative

 19,491   14,210   8,318   -   42,019 
                    

Depreciation and amortization of

property and equipment

 373   521   113   -   1,007 
                    

Amortization of acquired intangible assets

 -   95   -   -   95 
                    

Remeasurement of acquisition-related

contingent consideration

 -   (1,713)  -   -   (1,713)
                    

Gain on sale of assets

 -   (2,420)  -   -   (2,420)
                    

Operating income

$5,454  $5,370  $3,312  $-  $14,136 
                    

Total assets as of January 1, 2022

$32,809  $28,343  $8,676  $3,024  $72,852 

Property and equipment acquired

$563  $481  $173  $359  $1,576 

 

 

The Company derives a majority of its revenue from offices in the United States. Revenue reported for each operating segment are all from external customers. The Company is domiciled in the United States and its segments operate in the United States, Canada, Germany, Puerto Rico and Serbia. Revenue by geographic area for the fiscal years ended December 30, 2023, December 31, 2022 and January 1, 2022 are as follows:

 

  

Fiscal Year Ended

 
  

December 30,

  

December 31,

  

January 1,

 
  

2023

  

2022

  

2022

 

Revenue

            

United States

 $246,578  $272,342  $186,169 

Canada

  6,480   4,708   9,578 

Puerto Rico

  6,515   5,180   5,237 

Europe

  3,664   2,630   2,891 
  $263,237  $284,680  $203,875 

 

 

Total assets by geographic area as of the reported periods are as follows:

 

  

Fiscal Year Ended

 
  

December 30,

  

December 31,

  

January 1,

 
  

2023

  

2022

  

2022

 

Total Assets

            

United States

 $110,781  $81,558  $67,296 

Canada

  1,880   1,640   1,327 

Puerto Rico

  3,476   1,401   963 

Europe

  4,347   3,365   3,266 
  $120,484  $87,964  $72,852